Introduction
Epstein-Barr virus (EBV), the etiological agent of infectious mononucleosis, may have an indispensable role in the oncogenesis of EBV-related malignant diseases. It is well known that EBV is associated with endemic Burkitt lymphoma [1] and lymphoepithelioma of the nasopharynx [2] [3] [4] . In the past 15 years, EBV genomes have been identified in Hodgkin's disease [5] [6] [7] [8] , some types of T-cell lymphoma [9] , lymphoepitheliomas of various tissues [10] [11] [12] , malignant lymphoma arising in immunosuppressed patients [13, 14] , and pyothoraxassociated B-cell lymphoma [15, 16] .
Burke et al. [17] first reported the association of Epstein-Barr virus (EBV) with gastric lymphoepithelial carcinoma, in 1990, using a polymerase chain reaction (PCR) method. In 1991, Shibata et al. [18] demonstrated that EBV genomes were uniformly present in gastric lymphoepithelioma-like carcinoma cells and were not present in the reactive lymphoid infiltrate or normal mucosa. In 1992, Shibata and Weiss [19] indicated that EBV genomes were present not only in the rare lymphoepithelial gastric adenocarcinoma, but also in 16% of typical gastric adenocarcinomas in North America. In Japan, Tokunaga et al. [20, 21] reported that 6.6%-6.9% of gastric carcinomas were EBVrelated. After that, many authors reported the association of EBV with gastric carcinoma, noting a close relationship to lymphoepithelial morphology, a 6%-12% occurrence in ordinary gastric carcinoma, male predominance, and a higher frequency in the upper part of the stomach [22] [23] [24] [25] [26] [27] [28] . But there have been only a few reports concerning surrounding epithelia and infiltrating lymphocytes, and the exact route through which EBV could enter the epithelial cells is unknown. In this study, we investigated the association of EBV with gastric carcinoma and surrounding cells, using a PCR method and an in situ hybridization (ISH) method.
Patients and methods

Patients and specimens
One hundred and two cases of gastric carcinoma were studied. All specimens were obtained surgically from Japanese patients at the Department of General Surgery, Graduate School of Medicine, Chiba University. The mean age of the patients was 61.6 years. The maleto-female ratio was 1.8 to 1. For histological examination, tissues were fixed in 10% formalin and embedded in paraffin. Histologically, 40 cases were intestinal type, and the other 62 cases were diffuse type, by Lauren's classification [29] . In this series, one case of adenosquamous carcinoma was considered to be diffuse type, and one case resembled lymphoepithelioma of the nasopharynx. Concerning the depth of invasion, 37 cases were mucosal or submucosal cancer ("early cancer"), and in the other 65 cases, carcinoma cells involved the proper muscle or extended beyond it ("advanced cancer").
Polymerase chain reaction (PCR)
The specimens were first studied for the presence of the EBV genome by PCR with primers specific for a 153-base pair region of the EBV BamHI W fragment (primers: EBV1, 5ЈCACTTTAGAGCTCTGGAGGA3Ј; EBV2 5ЈTAAAGATAGCAGCAGCGCAG3Ј). DNA was extracted from six 10-µm-thick sections of formalinfixed paraffin-embedded tissues by the method described previously [22, 30] . To ascertain the reliability of DNA extraction, a 110-base pair region of the -globin gene was also amplified (primers: -globin 1, 5ЈACA CAACTGTGTTCACTAGC3Ј; -globin 2, 5ЈCAAC TTCATCCACGTTCACC3Ј). The PCR mixtures contained 1.0µg of DNA, 5 µl of 10ϫ Taq polymerase buffer (500 mmol/l KCl, 100mmol/l Tris-HCl, pH 8.4, 15mmol/l MgCl 2 , 0.1% gelatin, 0.2% Nonidet P-40; Sigma Chemical, St. Louis, MO, USA), 200µmol/l of each deoxynucleoside, 100 pmole of EBV or -globin primers, and 2.5 units of Taq polymerase (Perkin Elmer Cetus, Norwalk, CT, USA) in a final volume of 50µl. After an initial incubation for 3min at 94°C, the samples were subjected to 30 amplification cycles (1min at 94°C, 30 s at 54°C, 1.5min at 72°C; complete cycle, 8.5min) in a Thermal cycler (PC-700; ASTEC, Fukuoka, Japan). The PCR products were electrophoresed and visualized by ethidium bromide staining. The sensitivity of this method was calculated as a minimum of 800 copies of the EBV genome in the DNA sample [22] . In each experiment, EBV-containing RAJI cell DNA was used as a positive control, and a sample without DNA was used as a negative control. RAJI cells were a gift from the Japanese Cancer Research Resources Bank (Tokyo, Japan).
In situ hybridization (ISH)
All cases were also studied by ISH to determine the localization of EBV and to compare the sensitivity with that of PCR. ISH was performed, as we have previously mentioned, by using a digoxigenin-labelled 30mer-oligonucleotide probe (5ЈAGACACCGTCCTCACC ACCCGGGACTTGTA3Ј) which was complementary to small nuclear EBV-encoded RNA-1 (EBER-1) [22, 31] . Briefly, 4-µm-thick sections were cut from paraffin-embedded tissues, mounted on 3-aminopropyltriethoxysilan (Sigma Chemical, St Louis, MO, USA)-coated slides, baked at 60°C for 1h, and dewaxed. The sections were treated with 0.2N HCl for 20min and then with 20 µg/ml proteinase K (Boehringer Mannheim, Mannheim, Germany) solution. Then the slides were dehydrated and dried.
The prehybridization mixtures consisted of 50% deionized formamide, 5ϫ Denhardt's solution, 4ϫ saline-sodium phosphate-ethylenediaminetetraacetic acid (SSPE) (1ϫ SSPE: 0.18mol/l NaCl, 10 mmol/l NaH 2 PO 4 , 1 mmol/l ethylene-diaminetetraacetic acid; pH 7.4), 0.1% sodium dodecyl sulfate, 100µg/ml of denatured salmon sperm DNA, 100µg/ml of transfer RNA, and 10% dextran sulfate. After prehybridization for 2 h at 37°C, 20 µl of hybridization mixtures containing 1-2ng/µl of probe was pipetted onto tissue sections, covered with coverslips, and incubated at 37°C overnight. Then the slides were washed.
For the detection of the hybridization signal, the slides were treated for 30min with 0.5% blocking reagent solution (Boehringer), then with polyclonal sheep anti-digoxigenin alkaline phosphatase conjugate (1000-5000ϫ) for 30min. After a washing, the visualizing reaction was performed with nitroblue tetrazolium salt (NBT) and 5-bromo-4-chloro-3-indolyl phosphate (BCIP) solution in the dark for 6 to 12h. The slides were counterstained with methyl green and mounted with aqueous medium. As a positive control, lymphoepithelioma of the nasopharynx was used in each study. The specificity of the ISH method was mentioned previously [22] .
Results
DNA could be extracted in 99 of 102 cases (97.1%) and amplification of the -globin gene was observed in 97 of 99 cases (98.0%). Of these 97 informative cases, EBV was detected in 21 cases (21.6%) by the PCR method ( Fig. 1; Table 1 ). ISH studies clearly showed that EBV RNA was expressed in 5 of the 97 cases (5.2%) ( Table  1) and was localized to almost all nuclei of carcinoma cells (Fig. 2) . These 5 cases were all clearly PCRpositive (Fig. 1) . Clinically, all the above five lesions were found in male patients and arose in the proximal region of the stomach. Concerning depth of invasion, one case was submucosal cancer ("early cancer"), and in the other four cases, the cancer had invaded the proper muscle or beyond ("advanced cancer"). Histologically, three of the five cases were diffuse type and two were intestinal type, by Lauren's classification. One case was typical lymphoepithelioma-like carcinoma similar to nasopharyngeal carcinoma, and moderate lymphoid infiltration was observed in the other two cases of EBV-positive diffuse-type carcinomas (Table 2) .
In this study, EBV RNA was not detected in the nonneoplastic epithelia adjacent to carcinoma cells, but it was detected in 24 of the 97 informative cases (24.7%), in a few scattered small infiltrating lymphocytes in the lamina propria, by the ISH method (Fig. 3) . In the EBV-positive carcinomas, EBV-positive lymphocytes were observed in 4 of the 5 cases (80.0%), which was a significantly higher positive rate than that in EBVnegative gastric carcinomas (20 of 92 cases; 21.7%; P ϭ 0.01, Fisher's exact test) ( Table 3 ). The maximal density of EBV-positive lymphocytes was 1-4 per high-power field (ϫ200) in all EBV-positive cases.
Concerning EBV detection methods, our results showed no association between the PCR and ISH methods in the 92 cases of EBV-negative gastric carcinomas (Table 4 ). There were no significant clinical differences between the clinical characteristics of the PCR-positive and/or ISH-positive-lymphocyte cases and bothnegative cases (Table 5 ).
Discussion
The association of Epstein-Barr virus (EBV) with gastric lymphoepithelial carcinoma was first reported by Burke et al. [17] in 1990, using a PCR method. In 1991, Shibata et al. [18] demonstrated by PCR and ISH methods that EBV genomes were uniformly present in gastric lymphoepithelioma-like carcinoma cells and were not present in the reactive lymphoid infiltrate or normal mucosa. But in one of their seven cases (14.3%), an EBV sequence was detected in the normal mucosa, and an EBV sequence was detected in one of six normal lymph nodes (16.7%) by a PCR method [18] . Our previous report indicated that the EBV genome was detected by PCR in one case of normal gastric mucosa, which was negative by the ISH method [22] . In 1992, Shibata and Weiss [19] , using PCR and ISH methods, demonstrated that EBV genomes were present not only in the rare lymphoepithelial gastric adenocarcinoma, but also in 16% of typical gastric adenocarcinomas in North America. In Japan, using an ISH method, Tokunaga et al. [20, 21] reported that 6.6%-6.9% of gastric carcinomas were EBV-related. Many authors have reported a 6%-12% association of EBV with ordinary gastric carcinoma [22] [23] [24] [25] [26] [27] [28] . In our study, EBV was detected in 5.2% of gastric carcinomas by an ISH method, supporting the results of these studies.
However, there have been only a few reports concerning the association of EBV with surrounding epithelia and infiltrating lymphocytes. In 1994, Fukayama et al. [32] reported that the small nuclear EBV-encoded RNA-1 (EBER-1) signal was identified in the in- Fig. 3 . EBV RNA was detected in small infiltrating lymphocytes (arrow), by the ISH method, but was not detected in nonneoplastic epithelia, ϫ164 [33] showed EBV-positive lymphoid cells in 50% of gastric carcinomas and in 33% of colorectal carcinomas. In 1997, Hoshida et al. [34] reported that positive signals were found in two of eight cases (25.0%) in small lymphoid cells of gastric carcinoma in renal transplant recipients. Yanai et al. [35] reported that EBV-determined nuclear antigen (EBNA)-1 immunostaining was observed in all 19 cases of atrophic gastric mucosa examined. But this finding is not likely to be confirmed, because of an inconsistency with ISH results and because they used a biotin method. In our series, EBV RNA was not detected in normal gastric epithelia.
In 2001, Cho et al. [36] reported that EBV-positive lymphocytes were seen in 10.7% of gastric carcinomas, 5.6% of esophageal carcinomas, 7.5% of ampulla of Vater cancers, and 12.8% of colorectal carcinomas. In our study, EBV genomes were detected in 21.6% of cases by a PCR method and in 24.7% of cases in infiltrating lymphocytes by the ISH method. Moreover, EBV-positive lymphocytes were observed in the cardia, body, and antrum (Table 5 ). These findings indicate the scattered presence of EBV in lymphocytes in the digestive tract, and emphasise the need to use morphological methods when assessing the EBV status of malignant digestive tract tumors.
The exact route through which EBV can enter epithelial cells is unknown, but, recently, some authors reported the establishment of EBV-positive gastric epithelial cell lines [37, 38] . These cell lines may be useful for studying the interaction of EBV with gastric epithelial cells. In 1998, Imai et al. [39] demonstrated evidence for direct infection of various human epithelial cells by EBV in vitro. Cocultivation with virus produc- Differences between EBV-positive cases and EBV-negative cases, excluding EBV-positive gastric carcinoma, were not significant ers showed 800-fold-higher efficiency of infection than with cell-free infection, suggesting the significance of direct cell-to-cell contact as a mode of virus spread [39] . These cell lines and study systems will provide suitable materials for elucidating the interactions between EBV and epithelial cells.
In conclusion, EBV was detected in 5.2% of gastric carcinomas and in 24.7% of infiltrating lymphocytes by the ISH method. The high positive rate (21.6%) by the PCR method corresponds to the presence of the EBV genome in surrounding lymphocytes.
